Davidson Capital Management Inc. Moderna, Inc. Transaction History

Davidson Capital Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$85.37 - $115.44 $4,268 - $5,772	50 New	50 $5,000
Q3 2023 Oct 31, 2023	BUY	$96.41 - $126.61 $1,735 - $2,278	18 Added 64.29%	46 $4,000
Q2 2023 Aug 02, 2023	BUY	$118.5 - $160.53 $948 - $1,284	8 Added 40.0%	28 $3,000
Q1 2023 May 01, 2023	SELL	$135.66 - $197.02 $135 - $197	-1 Reduced 4.76%	20 $3,000
Q4 2022 Feb 07, 2023	BUY	$118.38 - $210.04 $473 - $840	4 Added 23.53%	21 $3,000
Q1 2022 May 17, 2022	BUY	$126.46 - $235.05 $2,149 - $3,995	17 New	17 $3,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Davidson Capital Management Inc. with notifications on news.